Bech P , Cialdella P , Haugh M C , Birkett M A , Hours A , Boissel J P , Tollefson G D (2000) Meta-analysis of randomised controlled trials of fluoxetine v. placebo and tricyclic antidepressants in the short-term treatment of major depression . Br J Psychiatry176: 421–428
2.
Buckley N A , McManus P R (2002) Fatal toxicity of serotoninergic and other antidepressant drugs: analysis of United Kingdom mortality data . BMJ325(7376): 1323–1323
3.
Cheeta S , Schifano F , Oyefeso A , Webb L , Ghodse A H (2004) Antidepressant-related deaths and antidepressant prescriptions in England and Wales, 1998–2000 . Br J Psychiatry184: 41–47
4.
Gunnell D , Saperia J , Ashby D (2005) Selective serotonin reuptake inhibitors (SSRIs) and suicide in adults: meta-analysis of drug company data from placebo controlled, randomised controlled trials submitted to the MHRA's safety review . BMJ330: 385-385
5.
Isacsson G , Holmgren P , and Ahlner J (2005) Selective serotonin reuptake inhibitor antidepressants and the risk of suicide: a controlled forensic database study of 14,857 suicides . Acta Psychiatr Scand111: 286–290
6.
Jick H , Kaye J A , Jick S S (2004) Antidepressants and the risk of suicidal behaviors . JAMA292: 338–343
7.
Mines D , Hill D , Yu H , Novelli L (2005) Prevalence of risk factors for suicide in patients prescribed venlafaxine, fluoxetine, and citalopram. Pharmacoepidemiol . Drug Saf14: 367–372
8.
Nutt D J (2005) Death by tricyclic: the real antidepressant scandal?J Psychopharmacol19: 123–124
9.
Wessely S , Kerwin R (2004) Suicide risk and the SSRIs . JAMA292: 379–381